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ABSTRACT
Splicing factor 1 (SF1) recognizes the branch point
sequence (BPS) at the 3′ splice site during the forma-
tion of early complex E, thereby pre-bulging the BPS
adenosine, thought to facilitate subsequent base-
pairing of the U2 snRNA with the BPS. The 65-kDa
subunit of U2 snRNP auxiliary factor (U2AF65) inter-
acts with SF1 and was shown to recruit the U2 snRNP
to the spliceosome. Co-immunoprecipitation experi-
ments of SF1-interacting proteins from HeLa cell ex-
tracts shown here are consistent with the presence of
SF1 in early splicing complexes. Surprisingly almost
all U2 snRNP proteins were found associated with
SF1. Yeast two-hybrid screens identified two SURP
domain-containing U2 snRNP proteins as partners
of SF1. A short, evolutionarily conserved region of
SF1 interacts with the SURP domains, stressing their
role in protein–protein interactions. A reduction of A
complex formation in SF1-depleted extracts could be
rescued with recombinant SF1 containing the SURP-
interaction domain, but only partial rescue was ob-
served with SF1 lacking this sequence. Thus, SF1
can initially recruit the U2 snRNP to the spliceosome
during E complex formation, whereas U2AF65 may
stabilize the association of the U2 snRNP with the
spliceosome at later times. In addition, these find-
ings may have implications for alternative splicing
decisions.
INTRODUCTION
Pre-mRNA splicing is essential for eukaryotic gene expres-
sion and one of the most versatile mechanisms to increase
proteome diversity through alternative splice site choices
(1). The reaction is catalyzed by the spliceosome, a multi-
megadalton complex (2). Five small nuclear ribonucleopro-
tein particles (U1, U2, U4, U5 and U6 snRNPs) and more
than 100 non-snRNP proteins assemble in a step-wise fash-
ion on the pre-mRNA through networks of RNA–RNA,
RNA–protein and protein–protein interactions to form the
catalytic center of the spliceosome for intron removal.
Essential sequence elements at the 5′ and 3′ splice sites
are recognized at the onset of spliceosome assembly (2).
U1 snRNP binds to the 5′ splice site, whereas SF1 and the
U2 snRNP auxiliary factor (U2AF) recognize distinct se-
quences at the 3′ splice site. SF1 and the large subunit of
U2AF (U2AF65) interact with one another and coopera-
tively bind the branch point sequence (BPS) and the ad-
jacent polypyrimidine tract, respectively (3–8). The small
U2AF subunit (U2AF35) recognizes the 3′ splice site AG
dinucleotide (9). Together these interactions assemble the
early complex E, which is converted into pre-splicing com-
plex A by incorporation of the U2 snRNP. This is accom-
plished through interaction of the U2 snRNP-associated
SF3b155 with U2AF65 (10), binding of U2 snRNP pro-
teins to and adjacent to the BPS (11–13) and base pairing
of the U2 snRNA with the BPS. These events are thought
to displace SF1 from the spliceosome (14). In addition, dis-
placement of the Saccharomyces cerevisiae ortholog of SF1,
termed branch point-binding protein (BBP; also known as
MSL5 or YLR116W) is thought to require the DExD-box
helicase Sub2p (15–17). The following steps of spliceosome
assembly involve binding of the remaining snRNPs and ad-
ditional non-snRNP proteins, juxtaposition of the splice
sites and dynamic remodeling of the complexes leading to
the formation of the catalytic center, followed by intron re-
moval in two catalytic steps (2).
SF1 was initially identified as a protein required for pre-
spliceosome assembly (18,19). It is evolutionarily conserved
and yeast BBP was shown to function in the formation
of the early commitment complex CC2, which together
with CC1 is the equivalent of the human E complex (14).
SF1 is essential in S. cerevisiae, Caenorhabditis elegans and
mammalian cells (4,20–23), but surprisingly, initial RNA
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interference-mediated knockdown of SF1 in human cells
did not affect the splicing of several pre-mRNAs tested (22).
Similarly, biochemical or genetic depletion of SF1/BBP
from human extracts or yeast cells only marginally affected
splicing activity, possibly due to a kinetic role for SF1 in
spliceosome assembly (14,24). Later experiments demon-
strated that SF1 is not involved in the splicing of all in-
trons, but influences alternative splicing decisions (25–28).
Thus, altered or mis-splicing of essential genes in the ab-
sence of SF1 could reflect its requirement for viability. In ad-
dition to its role in splicing, SF1 has been implicated in nu-
clear pre-mRNA retention and transcriptional repression
(29,30), functions that may contribute to or be the cause of
SF1’s essential phenotype.
To better understand SF1 function in splicing and poten-
tially other processes, we set out to identify interacting pro-
teins by co-immunoprecipitation (co-IPs) from HeLa cell
nuclear extracts combined with mass spectrometry (MS)
and in yeast two-hybrid (Y2H) screens with human SF1.
Our results confirm that the major role for SF1 is in early
stages of the splicing reaction.We demonstrate a novel func-
tion of SF1, which is essential for efficient spliceosome as-
sembly, in the initial recruitment of the U2 snRNP through
direct interactions with twoU2 snRNP-associated proteins.
The isolation of Y2H partners moreover suggests interac-
tions of SF1 with additional proteins implicated in splicing,
but also in other processes and identifies domains poten-
tially mediating these interactions.
MATERIALS AND METHODS
Co-IP of SF1-interacting proteins and MS
HeLa cell nuclear extract (corresponding to 2 mg of to-
tal protein) was incubated in the absence or presence of
0.3 mg/ml RNase A (Sigma) for 15 min at room temper-
ature followed by pre-clearing for 1 h at 4◦C with Pro-
tein G Sepharose (GE Healthcare) equilibrated in IP buffer
(50 mM Tris-HCl, pH 7.9, 100 mM NaCl, 0.05% Non-
idet P-40 [NP-40] and 0.5 mM dithiothreitol [DTT]). Un-
bound material was incubated for 1 h at 4◦C with Protein
G Sepharose-coupled anti-SF1 (Abnova; H7536-MO1A)
or control mouse IgG (Sigma, P4810), followed by cen-
trifugation at 2000 rpm in a microfuge for 2 min at 4◦C.
Unbound material was saved and the beads were washed
three times with 1 ml IP buffer. Bound material was eluted
with NuPAGE LDS sample buffer (Life Technologies) and
separated in NuPAGE Novex 4–12% Bis-Tris protein gels
(Life Technologies), followed by Coomassie blue staining.
Proteins were in-gel trypsin-digested and extracted accord-
ing to Shevchenko et al. (31). Peptides were analyzed in
an LTQ Orbitrap XL mass spectrometer (Thermo Fisher
Scientific) under standard conditions. Proteins were identi-
fied by searching fragment spectra against the NCBI non-
redundant database using Mascot as search engine. The
number of product ion spectra (total spectrum count) of
identified peptides was compared between anti-SF1 and
control-IgG samples. Proteins with more than 15% of spec-
tra in control IgG versus anti-SF1 were eliminated. Proteins
with five or more spectrum counts are shown in Table 1;
those with less than five spectrum counts, in addition to
proteins assumed to represent common contaminants, are
listed in Supplementary Table S1.
Y2H analysis
Y2H screens were performed with the partial coding se-
quence of human SF1 (amino acids 1–441; GenBank acces-
sion number gi: 295842308), which was PCR-amplified and
cloned into pB27 as a C-terminal fusion to LexA (N-LexA-
SF1-C). The construct was verified by sequencing and used
as a bait to screen random-primed and dT-primed cDNA
libraries constructed in pP6 (Table 2) with a mean insert
size of 900 bp. Library construction has been described (32).
pB27 and pP6 are derived from pBTM116 and pGADGH,
respectively (33,34).
Baits were screened using a mating approach with
YHGX13 (Y187 ade2–101::loxP-kanMX-loxP, mat) and
L40Gal4 (mata) yeast strains as described (35). The num-
ber of clones tested and histidine-positive clones are listed
in Table 2. Prey fragments of positive clones were PCR-
amplified and sequenced at the 5′ and 3′ junctions. Preys
from the dT-primed library were only sequenced at the
5′ junctions. The resulting sequences were used to iden-
tify the corresponding interacting proteins in the GenBank
database (http://www.ncbi.nlm.nih.gov/gene/) with a fully
automated procedure. A confidence score (Predicted Bio-
logical Score, PBS) was attributed to each interaction as de-
scribed (32).
Data set
The protein interactions from this publication have been
submitted to the IntAct Molecular Interaction Database
(36) at the International Molecular Exchange Consortium
(IMEx; http://www.imexconsortium.org/) and assigned the
identifier IM-23671. The data are presented in Supplemen-
tary Tables S2–9 and Supplementary Figures S4–S11 and
can also be browsed with the PIMRider data analysis soft-
ware at https://pimr.hybrigenics.com/ (SF1 project).
Cloning procedures
DNAs were amplified with the Expand High Fidelity PCR
System (Roche) according to the manufacturer’s instruc-
tions and suitable primers. Correct cloning was verified by
sequencing (Microsynth, Switzerland).
DNAs for bacterial expression of the GST-tagged
SURP1 of SF3a120 (amino acids 38–113), SURP2 of SF-
SWAP (amino acids 197–272) and the single SURP domain
of CHERP (amino acids 1–75) were cloned into the Gate-
way vector pDEST15 (Life Technologies). The plasmid en-
coding the GST-tagged U2AF homology motif (UHM) of
U2AF65 (amino acids 367–475) has been described (4).
Plasmids for bacterial expression of SF1 proteins were
cloned as follows: C-terminal truncations carrying N-
terminal His6-tags were cloned into the BamHI and EcoRI
sites of pTrcHisA (Life Technologies). N-terminal dele-
tions were cloned into the NcoI and EcoRI sites of
pETMBP-1a (a gift of Michael Sattler, Helmholtz Center
and Technical University, Munich), encoding proteins with
N-terminal His6-MBP tags. Internal deletions of SF1-C370
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in pETMBP-1a were generated by replacing the deleted
sequences with one (306–326 and Zn) or two (KH)
KpnI sites, encoding Gly and Thr. Internal sequences of
SF1 (127–302, 295–335 and 304–326) were cloned into the
NcoI/EcoRI sites of pETMBP-1a.
For transient expression of N-terminal GFP fusion pro-
teins in HeLa cells, SF1 sequences were cloned into the
Gateway vector pDEST53 (Life Technologies).
Templates for in vitro transcription of 3′ splice site pre-
mRNAs were generated by HindIII and BstEII digestion
of a pBluescript plasmid encoding the region spanning ex-
ons 1 and 2 of AdML pre-mRNA (37). The 3′ overhangs
were blunt-ended with T4 DNA polymerase (Promega) fol-
lowed by religation. The resulting pre-mRNA contains 51
nts of vector sequences, 75 nts of the 3′ end of AdML in-
tron 1 and 38 nts of exon 2. This plasmid was used to mu-
tate the original AdML BPS (UACUUAU) to a consensus
(UACUAAC) or weak (AAUUCAC) BPS with the Gene-
Tailor Site-Directed Mutagenesis System (Life Technolo-
gies).
Bacterial expression and purification of recombinant proteins
Plasmids encoding GST-tagged SURP domains and His6-
MBP-tagged SF1 proteins were transformed into E. coli
strain BL21 by heat shock. Plasmids encoding GST, GST-
U2AF65-UHM and His6-tagged SF1 proteins were trans-
formed into E. coli strain XL1-Blue by heat shock. Proteins
were expressed for 4 h at 37◦C after addition of isopropyl-
-D-thiogalactopyranoside (IPTG) to a final concentration
of 1 mM. Cells were harvested by centrifugation at 5000 ×
g for 10 min.
Cells expressing GST-tagged proteins were lysed in PBS
supplemented with complete protease inhibitors (Roche) by
sonication on ice and supplemented with Triton X-100 to a
final concentration of 1%. Proteinswere purifiedwith 500l
of a 50% suspension of glutathione agarose (Sigma) equili-
brated in PBS. Unbound proteins were removed by washing
three times with 10 ml PBS and GST-tagged proteins were
eluted with 5mMglutathione and 50mMTris-HCl, pH 8.0.
Cells expressing His6- or His6-MBP-tagged proteins were
lysed in 10 mM Tris-HCl, pH 8.0, 100 mM NaCl, 50 mM
Na phosphate, 8 M urea and complete protease inhibitors.
Proteins were purified on TALON Metal Affinity Resin
(BD Biosciences). Unbound material was removed by three
washes with lysis buffer containing 0.4 M NaCl and 20
mM imidazole and bound proteins were eluted with 0.1 M
EDTA, pH 8.0.
All recombinant proteins were dialyzed against D buffer
(38) supplemented with 3 mM MgCl2 and stored at
−80◦C. Purified proteins were quantified by SDS-PAGE
and Coomassie blue staining.
GST pull-down assays
Reactions containing 20 l of packed glutathione-agarose
beads (Sigma) and 0.056 nmole (corresponding to ≈2 g)
of GST fusion proteins in a total volume of 200 l NETN
(20 mM Tris-HCl, pH 8.0, 50 mM NaCl, 0.5% NP-40, 0.5
mM EDTA) were incubated for 30 min at 4◦C and washed
twice with 500 l NETN. His6- or His6-MBP tagged pro-
teins were added in a two-fold molar excess and the reac-
tion mixture was incubated for 45 min at 4◦C in a total
volume of 200 l NETN. Where indicated, purified pro-
teins were treated with 0.3 mg/ml of RNase A for 20 min
at room temperature and centrifuged at maximal speed in a
microfuge for 5min prior toGSTpull-down.Unbound pro-
teins were removed by three NETN washes. Proteins were
eluted from the beads with SDS sample buffer for 5 min
at 95◦C and separated by SDS-PAGE followed by western
blotting (39). Input and bound proteins were detected with
mouse monoclonal anti-His6 (Sigma; H1029); the amount
ofGST-tagged proteins was verified by incubation with rab-
bit anti-GST (A.K., unpublished). Goat anti-mouse and
anti-rabbit IRDye800 and 680LT (LI-COR) were used as
secondary antibodies and immune complexes were visual-
ized with the Odyssey Fc imaging system (LI-COR Bio-
sciences).
Cell culture, transient transfection and preparation of HeLa
cell lysates and nuclear extract
HeLa cells were grown at 37◦C with 5% CO2 in DMEM
(Sigma) supplemented with 10% FBS (Sigma), 2 mM L-
glutamine (Gibco), 100 u/ml penicillin and 100 g/ml
streptomycin (Gibco). Cells were plated in 10-cm culture
dishes 24 h prior to transfection. Cells were transfected at
60–70% confluencywith polyethylenimine (Brunschwig) ac-
cording to the manufacturer’s instructions and collected 72
h later. Whole cell lysates were prepared by lysis of trans-
fected cells in 50 mM Tris-HCl, pH 7.5, 100 mMNaCl, 1%
NP-40, 1mMDTT, 2mMEDTAand complete protease in-
hibitors for 30 min at 4◦C followed by centrifugation at 16
000 x g for 5min at 4◦C.HeLa cell nuclear extracts were pre-
pared according to Dignam et al. (38) and dialyzed against
buffer D.
Co-IPs
HeLa cell nuclear extract was incubated with 0.3 mg/ml
RNase A (Sigma) for 20 min at room temperature and
centrifuged in a microfuge at maximal speed for 5 min.
The supernatant (corresponding to 100 g of total pro-
tein) was incubated for 1 h at 4◦C with Dynabeads Pro-
tein G (Invitrogen) coated with anti-SF1 or control mouse
IgG. The unbound fraction was kept for western blotting
and beads were washed four times with 1 ml of 50 mM
Tris-HCl, pH 7.5, 100 mM NaCl, 0.05% NP-40 and 0.5
mM DTT. Bound proteins were eluted with SDS sam-
ple buffer for 5 min at 95◦C. Input, unbound and bound
material were separated by SDS-PAGE followed by west-
ern blotting with the following antibodies: mouse mono-
clonal anti-CHERP (Santa-Cruz; Sc-100650), rabbit anti-
H1 (Santa-Cruz; Sc-10806), mouse monoclonal anti-SF1
(Abnova; H7536-MO1A), rabbit anti-SF3a60 (40), mouse
monoclonal anti-SF3a66 (41), rabbit anti-SF3a120 (42),
rabbit anti-SFSWAP (Aviva; ARP 40524) and mouse mon-
oclonal anti-U2AF65 (Sigma; U4758). Secondary antibod-
ies and detection of immune complexes were as above.
For precipitation of transiently expressed GFP-tagged
SF1 and associated proteins, HeLa whole cell lysate (corre-
sponding to 6 mg of total protein per reaction) was treated
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with RNase A as above and incubated for 1 h at 4◦C
with Dynabeads Protein G-coupled goat anti-GFP (a gift
of Karla Neugebauer, Yale University). Washing, elution,
SDS-PAGE and western blotting were performed as above.
Proteins were detected with anti-SF3a120, anti-U2AF65
and rabbit anti-GFP (Invitrogen; A-11122).
Immunodepletion
SF1 was immunodepleted from HeLa cell nuclear extract
adjusted to 600 mMKCl by three passages over Dynabeads
Protein G-coupled anti-SF1. The depleted extract was di-
alyzed against buffer D (38) and stored at −80◦C. Mock
depletions were performed as above in the absence of anti-
body.
Spliceosome assembly
AdML pre-mRNAs with a consensus or weak BPS were
synthesized with T3 RNA polymerase (Promega) in the
presence of [-32P]UTP and gel-purified (37,43). Biologi-
cal triplicates of spliceosome assembly were performed in
10-l reactions in the presence of 10% untreated, mock- or
SF1-depleted HeLa nuclear extract, 10 mM Hepes-KOH,
pH 7.9, 50 mM KCl, 0.05 mM EDTA, 0.25 mM DTT, 1
g tRNA and 1.6 pmol pre-mRNA at 30◦C for the times
shown in the figure legends.Where indicated, reactions were
complemented with 0.022, 0.22 or 2.2 pmol SF1-C370 or
SF1–302. Reaction products were separated in native 4%
polyacrylamide gels (44). Gels were dried and exposed to
PhosphorImager screens. Quantification was done with the
Molecular Imager FX (BioRad) and softwareQuantityOne
V 4.2.1 (BioRad).
UV cross-linking and IP of U2AF65
Spliceosome assembly was performed as above in 20-l re-
actions in the presence of 25% mock- or SF1 depleted ex-
tract and 18 pmol pre-mRNA. Samples were incubated at
30◦C for 15min, UV cross-linked and treated withRNaseA
as described (45). Dynabeads Protein G coupled with con-
trol IgG or anti-U2AF65 and 100 l buffer D (38) were
added and samples were incubated for 1.5 h at 4◦C with
rotation. After centrifugation, the beads were washed four
times with 600 l of 50 mM Tris-HCl, pH 7.5, 0.5 MNaCl,
1% NP-40 and 0.5 mM DTT, and once with 50 mM Tris-
HCl, pH 7.5 and 1% NP-40. Bound material was eluted by
boiling in SDS loading buffer for 5 min, followed by cen-
trifugation and separation by 10% SDS-PAGE. Gels were
dried, exposed to a PhosphorImager screen and signals were
quantified as above.
RESULTS
The U2 snRNP co-immunoprecipitates with SF1
To identify potential novel partners of SF1, we performed
co-IPs of HeLa cell nuclear extracts followed by MS. Ex-
tracts were incubated in the absence or presence of RNase
A, pre-cleared on ProteinGSepharose and aliquots were in-
cubated with Protein G Sepharose-coupled control mouse
IgG or a monoclonal antibody directed against the N-
terminal 110 amino acids of SF1. Eluted proteins were
separated by 1D PAGE (Supplementary Figure S1), in-gel
trypsin-digested and analyzed by liquid chromatography
tandem mass spectrometry (LC-MSMS).
A total of 58 proteins were specifically precipitated by
anti-SF1 (Table 1), four of which were previously re-
ported to directly interact with SF1: FBP11/PRPF40A,
PUF60, SPF45/RBM17 andU2AF65/U2AF2, (3,4,20,46–
48). Forty-seven proteins are represented in a list of 244 an-
notated spliceosomal proteins (see 49). Among these, 29 are
associated with the U1 or U2 snRNPs or function in pre-
splicing complex A assembly. Eight are part of the U4/U6,
U5 or U4/U6.U5 snRNPs or function after A complex for-
mation. Three members of the SR family of proteins with
functions early and late during spliceosome assembly were
found, in addition to six proteins with roles in mRNA ex-
port ormRNAbinding and onemiscellaneous protein asso-
ciated with the spliceosome. Thus, consistent with the func-
tion of SF1 at the initial steps of spliceosome assembly,
more than half of the proteins co-precipitating with SF1 are
components of early spliceosomes, compared to 52 of the
annotated early spliceosomal proteins (excluding SR and
hnRNP proteins), whereas only a small percentage (eight of
103 proteins) are associated with later complexes. An addi-
tional 14 spliceosome-associated proteins were detected be-
low the cut-off used for the data in Table 1 and are listed in
Supplementary Table S1, together with proteins not known
to be part of the spliceosome or to be common contami-
nants.
A closer inspection of the early spliceosomal proteins pre-
cipitated by anti-SF1 revealed the presence of nine of the
12 U2 snRNP-specific proteins, as well as nine of 11 pro-
teins more loosely associated with the U2 snRNP (Table 1,
U2 and U2-related, respectively; see 50). This finding was
surprising, since the U2 snRNP is thought to replace SF1
from the spliceosome during the complex E to A transi-
tion by binding of the U2 snRNP-associated SF3b155 to
the U2AF65-UHM, a site occupied by SF1 in complex E
(14,51–53) and base pairing of the U2 snRNA with the
BPS.Moreover, SF1 has not been found amongU2 snRNP-
associated proteins (50). However, although the U2 snRNA
base-pairs with the BPS only in complex A (54), the U2
snRNP has been detected already in complex E (55–57).
Eleven proteins isolated by co-IP are not known to be re-
lated to splicing (Table 1). Most are nuclear proteins with
functions in RNA binding and/or transcription. The pres-
ence of some of these proteins may be due to interactions
with other components of the splicing machinery that are
directly or indirectly associated with SF1.
SF1 interacts with U2 snRNP-associated proteins in the Y2H
system
Information regarding potential direct SF1 partners was
obtained from Y2H screens with residues 1–441 of human
SF1 fused to the C terminus of the LexA DNA binding do-
main. This portion of SF1 contains all domains required for
function in in vitro splicing assays (4), but lacks most of the
Pro-rich C-terminal region, previously shown to strongly
activate transcription in theY2H system (4). cDNAs of four
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Table 1. Proteins immunoprecipitated with anti-SF1 antibodies from HeLa cell nuclear extracts
SF1 IgG
Name1 Symbol2 Gene ID3 Group4 − RNase + RNase − RNase + RNase
Sm-B/B’ SNRPB 6628 Sm 51 20 1 2
Sm-E SNRPE 6635 Sm 48 15 1 2
Sm-G SNRPG 6637 Sm 7 13 1 1
U1–70K SNRNP70 6625 U1 15 10 0 0
U1-A SNRPA 6626 U1 39 29 1 2
SRPK1 SRPK1 6732 U1 0 6 0 0
U2-A’ SNRPA1 6627 U2 27 19 0 1
U2-B” SNRPB2 6629 U2 12 10 0 0
SF3a120* SF3A1 10291 U2 41 47 6 5
SF3a60 SF3A3 10946 U2 23 28 1 2
SF3b155 SF3B1 23451 U2 76 66 9 5
SF3b145 SF3B2 10992 U2 47 50 0 3
SF3b130 SF3B3 23450 U2 96 93 6 7
SF3b14a SF3B14 51639 U2 17 10 1 1
SF3b10 SF3B5 83443 U2 7 9 0 0
CHERP* CHERP 10523 U2-related 34 15 0 0
SF3b125 DDX42 11325 U2-related 4 19 0 0
hPRP43 DHX15 1665 U2-related 55 66 6 10
SPF31 DNAJC8 22826 U2-related 7 10 1 1
PUF60 PUF60 22827 U2-related 22 26 0 1
SPF45 RBM17 84991 U2-related 10 7 0 0
U2SURP* SR140 23350 U2-related 41 41 1 0
U2AF65 U2AF2 11338 U2-related 27 34 0 1
U2AF35 U2AF1 7307 U2-related 10 11 1 1
FBP11 PRPF40A 55660 A 8 15 0 0
S164 RBM25 58517 A 16 14 0 0
RBM39 RBM39 9584 A 0 8 0 0
SF1 SF1 7536 A 185 193 0 0
SUGP1* SF4 57794 A 0 6 0 0
SRp40 SFRS5 6430 SR 8 4 0 0
SRp55 SFRS6 6431 SR 8 4 0 0
9G8 SFRS7 6432 SR 22 18 3 1
CYPH PPIH 10465 U4/U6 7 5 1 0
hPRP31 PRPF31 26121 U4/U6 6 7 0 0
hPRP28 DDX23 9416 U5 1 5 0 0
hPRP6 PRPF6 24148 U5 18 9 1 2
hSNU66 SART1 9092 U4/U6.U5 7 3 0 0
CDC5L CDC5L 988 Prp19 5 7 0 0
hSmu1 SMU1 55234 B 1 7 0 0
SRm300 SRRM2 23524 B (act) 0 7 0 0
TOE1 TOE1 114034 C2 2 5 0 0
Acinus ACIN1 22985 EJC/TREX 18 26 0 0
THOC2 THOC2 57187 EJC/TREX 9 4 0 0
ARS2B ARS2 51593 mRNA 52 45 2 2
CBP80 NCBP1 4686 mRNA 24 24 1 3
CBP20 NCBP2 22916 mRNA 9 0 1 0
ZC3H18 ZC3H18 124245 mRNA 9 11 0 0
ZNF207 ZNF207 7756 misc. 5 2 0 0
ANXA6 309 5 0 0 0
BRD2 6046 0 18 0 0
CDK11B 984 3 5 0 0
CKB 1152 5 3 0 0
EIF3A 8661 12 3 0 0
EIF3C 8663 6 1 0 0
HSPA4L 22824 13 16 1 2
PCNP 57092 8 2 0 0
SAFB2 9667 7 1 0 0
ZFR 51663 10 0 0 0
ZNF598 90850 0 5 0 0
Proteins were separated by 1D PAGE (see Supplementary Figure S1) and identified by LC-MSMS. The total spectrum count is shown. The experimental
set-up is described in the Materials and Methods section. SF1 or IgG, proteins precipitated by anti-SF1 antibodies or control IgG coupled to Protein G
Sepharose; - RNase or + RNase, HeLa extracts were incubated without (−) or with (+) RNase A prior to IP. Raw data were filtered (see Materials and
Methods section) and the final list was compared to 244 spliceosomal proteins annotated in Supplementary Table S1 of Hegele et al. (49).
1Protein name commonly used in the splicing field. Proteins shown in bold are known SF1 partners; underlined, proteins also found in Y2H screens
(Table 3); *, proteins with SURP domains.
2NCBI ENTREZ symbol.
3NCBI ENTREZ GeneID.
4Operational classification of spliceosomal proteins according to Hegele et al. (49).
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Table 2. Libraries used in Y2H screens
Library name Description
Number of
clones tested Histidine- positive
CEMC7 RP1 Human T cell line CEMC7 53 × 106 70
HBMEC RP1 Human bone marrow endothelial cells (cloned cells transformed by SV40) 58 × 106 353
HTH RP1 Human thymocytes, CD4+CD8+ double positive cells from children 35 × 106 104
HTH dT2, 3 Human thymocytes, CD4+CD8+ double positive cells from children 88 × 106 97
PLA RP1 Human placenta 105 × 106 211
MANE RP1 Mouse adult neurosphere cells (free-floating clusters of neural stem cells) 65 × 106 284
MKI RP1 Total kidney, adult C57BL/J6 mice, age 8–10 weeks 102 × 106 144
MPC RP1 Mouse pancreatic cells (beta-cell line, betaTC-tet) 71 × 106 143
1RP, random-primed.
2dT, oligo-dT-primed.
3Performed in the presence of 0.5 mM 3-amino-1,2,4-triazole.
human and three mouse tissues or cell lines fused to the
Gal4 activation domain were tested for interactions (Ta-
ble 2).
As summarized in Table 3 (and listed in detail in
Supplementary Tables S2–S9), previously described SF1
partners were detected in the Y2H screens (ABL1/2,
PRPF40A/FBP11, RBM17/SPF45, U2AF65 and
UHMK1/KIST; 3,4,20,46,48,58,59), with U2AF65
showing an expectedly high confidence score (Predicted
biological score, PBS; Table 3). Several spliceosome-
associated proteins and other proteins with roles in splicing
were among the potential partners. However, only few
proteins found in complex with SF1 by co-IP/MS were
detected, suggesting that the majority of these were not
direct binding partners, but co-precipitated with SF1 from
HeLa cell extracts due to the numerous protein–protein
interactions in the spliceosome (2).
The highest PBS was found for KPNA2 (Table 3), a sub-
unit of the nuclear import complex. Other members of the
same complex were also detected, but with a lower PBS de-
pending on the subunit or cell type. Moreover, KIAA0907
was found as a SF1 partner with very high confidence in
all cell types tested. Roles in splicing for this protein, also
termed BLOM7, have been described (60). It contains aKH
domain, similar to a few other proteins found in the Y2H
screens with a lower PBS. Apart from these, SF1 may also
directly interact with proteins containing RNA recognition
motifs (RRMs) or zinc fingers. A possible relation of these
proteins to SF1 function will be described in the discussion.
Among the preys with reported roles in splicing are two
U2 snRNP-associated proteins: splicing factor SF3A sub-
unit 1 (SF3A120/SF3a1) and calcium homoeostasis endo-
plasmic reticulum protein (CHERP; Table 3). SF3a120 is
part of a heterotrimeric complex with SF3a66 and SF3a60
and essential for U2 snRNP function in spliceosome assem-
bly (61). CHERP was originally identified as an endoplas-
mic reticulum protein involved in the regulation of intracel-
lular Ca2+ homoeostasis (62), but is also loosely associated
with the U2 snRNP, and has been reported to localize to
the nucleus and function in alternative splicing (50,63,64).
Inspection of cDNA fragments of these proteins recov-
ered in the Y2H screens indicated that suppressor of white-
apricot/Prp21 (SURP) domains (65) may mediate the in-
teraction with SF1 (Figure 1A, Supplementary Tables S2–
S9 and Supplementary Figures S4–S11). SURP domains
are ≈40 amino acids long, often arranged in tandem and
all known SURP domain-containing proteins are involved
in splicing (66). Thus far, only the function of the second
SURP domain of SF3a120 as a protein–protein interac-
tion module has been established (66–68). The Y2H screens
identified SURP1 of SF3a120 and the single SURP domain
of CHERP as potential SF1 binding domains (Figure 1A
and Supplementary Figures S4–S11). Moreover, the sup-
pressor of white-apricot homolog (SFSWAP/SFRS8), an
alternative splicing factor with two SURP domains (65,69–
72) was detected in the Y2H screens (Table 3), with its sec-
ond SURP domain potentially interacting with SF1 (Fig-
ure 1A and Supplementary Figures S4–S11). Two addi-
tional proteins containing SURP domains were found by
co-IP (Table 1), the U2 snRNP-associated SURP motif-
containing protein (U2SURP/SR140) and the A complex
component SURP andG-patch domain-containing protein
1 (SUGP1/SF4; 50,73).
Together, these data suggest that SF1 binds U2 snRNP-
associated proteins and SFSWAP via SURP domain-
mediated interactions.
SF1 directly binds SURP domains of SF3a120, CHERP and
SFSWAP
To validate binding of SF1 to SURP domains, we first per-
formed co-IPs with anti-SF1 coupled toDynabeads Protein
G from RNase A-treated HeLa cell nuclear extracts and
western blotting with antibodies against the potential in-
teracting proteins. Figure 1B shows that SF3a120, as well
as SF3a60 and SF3a66 were co-precipitated with SF1; thus,
the entire SF3a heterotrimer was bound. CHERP was also
found in the precipitate; however, SFSWAP was not de-
tected. U2AF65, known to interact with SF1 (4,20) and
used as a positive control, was bound to SF1, whereas hi-
stone H1, a negative control, was not. None of the pro-
teins were bound to Dynabeads Protein G coated with non-
specific IgG. These results show that SF3a120 and CHERP
can be co-precipitated with SF1 from HeLa cell extracts,
whereas an interaction with SFSWAP was not detected.
To determine whether SF1 binding to SF3a120, CHERP
and SFSWAP was mediated by direct interactions with
the SURP domains identified in the Y2H screens, we per-
formed GST pull-down assays with GST-tagged SURP do-
mains and recombinant His6-tagged SF1-C370 (containing
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amino acids 1–370, i.e. the region common to all SF1 iso-
forms). His6-SF1-C370 was bound by the SURP domains
of SF3a120, CHERP and SFSWAP, as well as by the posi-
tive control, GST-U2AF65-UHM, but not by GST alone
(Figure 1C). The interactions were insensitive to RNase
A treatment prior to GST pull-down, demonstrating that
SURP domain binding of SF1 was not mediated by RNA.
Thus, SURP1 of SF3a120, the single SURP domain of
CHERP and SURP2 of SFSWAP are sufficient for direct
SF1 binding, confirming the results of the Y2H screens.
An evolutionarily conserved domain in SF1 is essential for
SURP domain binding
The region of SF1 responsible for the SURP domain inter-
action was analyzed in GST pull-down assays with His6-
tagged C- and N-terminal as well as internal deletion mu-
tants of SF1 (Figure 2A). Compared to SF1-C370, binding
to GST-SF3a120-SURP1, CHERP-SURP and SFSWAP-
SURP2 was slightly weakened with SF1-C327 and strongly
reduced upon deletion to amino acid 320 (Figure 2B). Bind-
ing of SF1-C315 was barely detectable and further deletion
of SF1 residues completely abolished the SURP domain in-
teraction. Thus, the C-terminal border of the SURP inter-
action domain (ID) lies between SF1 residues 315 and 327.
SF1 mutants with N-terminal His6 and maltose-binding
protein (MBP) tags were used to further delimit the SF1
SURP-ID. N-terminal deletions up to, and including the
zinc knuckle (N127 to N292; Figure 2C) did not abolish
binding of SF1 to the SURPdomains. Thus, neither the SF1
KH/QUA2 domain nor the zinc knuckle are involved in the
interaction, which was confirmed with SF1 mutants carry-
ing internal deletions of these domains (KH and Zn).
SF1 residues 295–335 were barely sufficient for the interac-
tion and amino acids 127–302 or 304–326 did not bind the
SURP domains. Moreover, an internal deletion of residues
306–326 abolished binding. TheC-terminal or internal dele-
tions did not affect binding to GST-U2AF65-UHM, used
as a positive control, whereas none of the N-terminal dele-
tions interacted withGST-U2AF65-UHM, since theU2AF
ligand motif (ULM) of SF1 was not present. Binding to
GST alone was not observed. Together, these data indicate
that the region between residues 293 and 327 of SF1 is re-
quired for the interaction with SURP domains.
To further test the relevance of this domain for SURP
binding, GFP-tagged SF1-C370 and -C302 were tran-
siently expressed in HeLa cells. RNase A-treated whole
cell lysates were immunoprecipitated with Dynabeads Pro-
tein G-coupled anti-GFP. SDS-PAGE and western blot-
ting with anti-SF3a120 showed that endogenous SF3a120
interacted with GFP-SF1-C370 but not -C302, whereas
U2AF65 bound both proteins (Figure 2D). Thus, the SF1
SURP-ID identified in vitro with recombinant proteins is
also essential for binding SF3a120 in HeLa cell lysates.
A multiple sequence alignment of SF1 revealed the pres-
ence of a region well-conserved from Drosophila to hu-
mans (amino acids 293–326 of human SF1; Figure 2E)
encompassing the residues that eliminated the SURP do-
main interaction. This region is highly conserved in mam-
mals, Xenopus and zebrafish, and partial conservation of
key residues (amino acids 301–321) is seen in other organ-
isms, including Arabidopsis, Schizosaccharomyces pombe
and Dictyostelium, with the exception of S. cerevisiae.
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Figure 1. Analysis of the interaction of SF1 with SURP domain-containing proteins. (A) Scheme of SURP domain-containing proteins identified in Y2H
screens. The domain structure of SF3a120, CHERP and SFSWAP is shown with SURP domains indicated in dark grey. Other domains are shown in light
grey: CID, RNA polymerase II-binding domain; G-patch, G-patch domain; RS domain, Arg/Ser-rich domain; UBL, ubiquitin-like domain. Numbering
was taken from UniProt entries (www.uniprot.org). The smallest selected interaction domain (SID) deduced from cDNAs found in the Y2H screens is
indicated below the proteins (numbering according to human proteins). (B) Co-IP. HeLa cell nuclear extract was incubated with Dynabeads Protein G
coated with anti-SF1 or control IgG. Input (I; 10% of total), bound (B) and unbound (U) fractions were separated by 7.5% SDS-PAGE (10% for anti-H1)
followed by western blotting with antibodies against the proteins indicated on the right side of each panel. (C) GST pull-down. His6-tagged SF1-C370
was incubated with GST alone, GST-tagged U2AF65-UHM, SF3a120-SURP1, CHERP-SURP or SFSWAP-SURP2 bound to glutathione-agarose as
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protein markers is indicated in kDa on the left.
From these results we conclude that an evolutionarily
conserved domain in SF1, spanning amino acids 293–327
is essential for binding SURP domains.
The SF1/SURP interaction is required for efficient early
spliceosome assembly
The above results demonstrate that SF1 can bind the
U2 snRNP through direct interactions with SF3a120 and
CHERP. SF1 recognizes the BPS in complex E and the U2
snRNP is weakly bound to this complex before base pair-
ing of the U2 snRNA to the BPS and pre-mRNA bind-
ing of several U2 snRNP-associated proteins in complex A
(5,10,13,56,57). To test the possibility that SF1 is involved
in the recruitment of the U2 snRNP to the pre-mRNA, we
compared spliceosome formation in HeLa cell nuclear ex-
tracts and SF1-depleted extracts in the absence or presence
of recombinant SF1 proteins with or without the SURP-
ID. To facilitate quantification of the results, spliceosome
assembly was analyzed with an AdML pre-mRNA lacking
the 5′ splice site and containing 75 nts of the 3′ end of in-
tron 1 and part of exon 2. Similar splicing substrates are
efficiently assembled into a 3′ splice site complex related to
pre-splicing complex A (termed A3’ complex hereafter) but
not converted to complex B (43). In addition, the original
BPS of AdML intron 1 was changed to the yeast consen-
sus BPS, UACUAAC, which is the optimal BPS for mam-
malian splicing (74) and also the preferred binding site of
SF1 (5,25,75).
Immunodepletion with anti-SF1 bound to Dynabeads
Protein G resulted in a 91% reduction of different SF1
isoforms compared to untreated or mock-depleted nuclear
extracts (Figure 3A). Other proteins, such as U2AF65
or SF3a120, were not co-depleted (Supplementary Figure
S2A). A3’ complex formation tested by incubation for 30
min at 30◦C in triplicate experiments was reduced to an
average of 44% of that seen in the mock-depleted extract
(Figure 3B). The SF1-depleted extract was then comple-
mented with equivalent concentrations of His6-SF1-C370
or -C302 (Supplementary Figure S3), containing or lack-
ing the SURP-ID, respectively (Figure 2A and B). Addition
of SF1-C370 rescued A3’ complex formation to 160% com-
pared to mock-depleted extract in a dose-dependent man-
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identical in more than 50% of the sequences are marked.
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ner, whereas complex formation in the presence of SF1-
C302 was less efficient (126%; Figure 3B). The observation
that the recombinant proteins rescued A3’ complex assem-
bly to more than 100% could be due to the fact that their
concentration exceeded that of endogenous SF1. Compar-
ison of protein levels of endogenous and recombinant pro-
teins is difficult, because endogenous SF1 exists in multi-
ple isoforms (Figure 3A; 76) and their exact contribution to
splicing is not established.
A rather modest effect of SF1 depletion on spliceosome
formation, despite an at least 98% reduction in SF1 protein
has been reported by Guth and Valca´rcel (24). The same
authors showed that the effect of SF1 depletion was more
pronounced with a pre-mRNA containing a weak as com-
pared to a strong BPS. Similarly, depletion of SF1 in yeast
causes more severe splicing defects with reporters contain-
ing mutated splice sites (14). We therefore repeated the ex-
periment with the same pre-mRNA as above, but contain-
ing the weak IgM BPS (AAUUCAC; 24,77). Compared to
mock-treated extract, SF1 depletion reduced complex for-
mation to about 23% (Figure 3C). Complementation with
SF1-C370 rescued A3’ complex formation to nearly mock-
depleted levels (98%), whereas addition of SF1-C302 re-
sulted in a significantly reduced rescue of 58%. Thus, the
region of SF1 necessary for the interaction with U2 snRNP
proteins is also required for efficient A3’ complex assembly.
The more marked effect seen with the pre-mRNA contain-
ing a suboptimal BPS can be explained by the fact that the
consensus BPS is the preferred SF1 binding site (5,25,75).
Previous studies suggested a kinetic role for SF1 in
spliceosome assembly (14,24). The above results indicate
that SF1 binds twoU2 snRNP proteins and the SF1 SURP-
ID is required for efficient A3’ complex formation. To test
whether the SF1-U2 snRNP interaction underlies the ki-
netic role of SF1, we performed a time course of A3’ com-
plex formation. Pre-mRNAs with a consensus or weak BPS
were incubated with mock- or SF1-depleted HeLa nuclear
extract supplemented with His6-SF1-C370 or -C302. Rep-
resentative results of experiments performed in triplicate are
shown in the top panels of Figure 4A and B. A3’ com-
plex formation was quantified and normalized to the val-
ues for the 60-min time points of the mock-depleted ex-
tract (bottom panels). SF1 depletion resulted in a 65 or
76% reduction in A3’ complex assembly with pre-mRNAs
containing a consensus or weak BPS, respectively. Addition
of SF1-C370 rescued complex formation to the levels of
mock-depleted extract with both pre-mRNAs. When reac-
tions were complemented with SF1-C302, A3’ complex for-
mation with the consensus BPS substrate was reduced only
at the 45 and 60-min time points, plateauing at 70%. In con-
trast, A3’ complex formation performed in the presence of
SF1-C302 and the pre-mRNAwith a weak BPS was less ef-
ficient at all time points, with a maximum level of 43% at 60
min. Thus, the interaction between SF1 and the U2 snRNP
is essential for efficient A3’ complex formation, especially
when U2 snRNA/BPS base pairing is suboptimal. This ob-
servation can explain the previously reported kinetic effect
on spliceosome assembly (24).
The absence of the SF1 SURP-ID does not compromise
U2AF65 binding to the RNA
SF1 and U2AF65 cooperatively bind the pre-mRNA and
increase each others affinity for RNA (3). Thus, SF1
depletion also causes decreased binding of U2AF65 to
the polypyrimidine tract with a concomitant decrease in
spliceosome assembly (24), which likely contributes to the
lower levels of A3’ complex formation seen above. To rule
out the possibility that RNA binding of U2AF65 is af-
fected in a SF1-depleted extract complemented with re-
combinant SF1 proteins, we performed UV cross-linking
of U2AF65 in 15-min reactions containing mock- or SF1-
depleted extracts and pre-mRNAswith a consensus orweak
BPS. Triplicate samples were UV cross-linked, RNase A-
treated and incubated with Dynabeads Protein G-coupled
control IgG or anti-U2AF65. Boundmaterial was analyzed
by SDS-PAGE and the fraction of RNA bound to U2AF65
was quantified (Figure 5). U2AF65 efficiently cross-linked
to both pre-mRNAs in the mock-depleted samples. Only
background cross-linking was detected in IPs performed
with control IgG. As expected from previous results (24),
pre-mRNAbinding of U2AF65 was partially reduced upon
SF1 depletion. However, addition of either His6-SF1-C370
or -C302 increased U2AF65/RNA binding to the levels
seen in mock-depleted extract, consistent with the fact that
both proteins contain the ULMand thus can bindU2AF65
(Figure 2B). We therefore conclude that the reduced lev-
els of A3’ complex formation observed in SF1-depleted ex-
tracts complemented with SF1-C302 are due to the lack of
interaction of SF1 with the U2 snRNP and not caused by
decreased pre-mRNA binding of U2AF65.
DISCUSSION
Results from co-IP/MS experiments and Y2H screens have
provided information about novel and, in part, unexpected
partners of SF1. The co-IP/MS experiment demonstrated
that about half of the proteins co-precipitated with SF1
from HeLa cell nuclear extracts are involved in early steps
of spliceosome assembly, confirming an early role for SF1
in splicing (19,20). Surprisingly, most of the U2 snRNP-
associated proteins were co-precipitated with SF1. Y2H
screens revealed potential interactions of SF1 with the
SURP domain-containing, U2 snRNP-associated proteins
SF3a120 andCHERP, as well as the alternative splicing fac-
tor SFSWAP. Direct binding of SF1 to SURP domains of
the three proteins were confirmed in GST pull-down assays
and the interaction domain was mapped to an evolutionar-
ily conserved, central region of SF1. We furthermore show
that the SF1/U2 snRNP interaction is necessary for effi-
cient spliceosome assembly, suggesting a role for SF1 in the
early recruitment of the U2 snRNP to the pre-mRNA.
A novel role for SF1 in U2 snRNP recruitment
Consistent with a role for SF1 at the onset of spliceosome
assembly (19,20), anti-SF1 antibodies precipitated more
than half of the proteins present in early splicing complexes,
compared to only 8% of proteins associated with later com-
plexes or functioning in splicing catalysis and post-splicing
events (Table 1; 2,49). However, although only five of 18
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Figure 5. Deletion of the SF1 SURP-ID does not reduce U2AF65 binding to the pre-mRNA. (A) and (B) U2AF65 UV cross-linking to AdML 3′ splice
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annotated A complex components were co-precipitated, al-
most all U2 snRNP-associated proteins were present. This
finding was unexpected, since the events leading to sta-
ble pre-mRNA binding of the U2 snRNP at the time of
A complex assembly are thought to trigger the release of
SF1 at the same time. In S. cerevisiae SF1 (BBP) was de-
tected in the ATP-independent commitment complex 2, but
not the pre-spliceosome (14). In the human system pro-
teins in the ≈80-kDa range, most likely representing SF1
isoforms, cross-link to the BPS in a U1 snRNP-dependent
andATP-independentmanner at very early times of spliceo-
some assembly (78). These cross-links disappear in the pres-
ence of ATP and are replaced by cross-links to proteins
of 14, 35 and 150 kDa, which persist in complex A. The
14-kDa protein is SF3b14a/p14, a U2 snRNP protein di-
rectly binding to the BPS adenosine (11,12,78). The 150-
kDa protein probably represents SF3b155, a U2 snRNP
component binding upstream and downstream of the BPS
and interacting with the U2AF65-UHM, the same site oc-
cupied by SF1 (10,51,53). In addition, a ‘U2 mimic’, an
oligoribonucleotide base-pairing to the BPS and neighbor-
ing sequences, prevents BPS binding of SF1 (3). Finally,
SF1 has only been detected in small amounts in A com-
plexes isolated from HeLa cells under physiological con-
ditions and the material used could have contained small
amounts of E complexes (79). These findings imply that the
SF1/U2 snRNP interaction occurs prior to A complex for-
mation. Since the U2 snRNP has been detected in complex
E (55–57), our data strongly suggest that SF1, binding to the
SURP domains of SF3a120 or CHERP, aids the initial re-
cruitment of the U2 snRNP to the assembling spliceosome.
We envision the following series of events: SF1 and
U2AF65 interact with one another, involving the ULM at
the N terminus of SF1 and the UHMof U2AF65 (51). This
is followed by their cooperative binding to the BPS and the
polypyrimidine tract (3). SF1 binds the BPS through its
KH domain (6), leaving the SURP-ID available for bind-
ing SF3a120 or CHERP. The SF1/BPS interaction pre-
bulges the BPS adenosine, whereas other nucleotides are ac-
cessible for U2 snRNA base pairing (6). In principle, SF1
could interact with the U2 snRNP before or after bind-
ing to U2AF65; in either case it would position the U2
snRNP close to the BPS. The transition to complex A then
occurs through replacement of the SF1/U2AF65 interac-
tion by binding of SF3b155 to the U2AF65 UHM, binding
of SF3b14a/p14 to the BPS adenosine, base pairing of U2
snRNA to the BPS and binding of SF3a and SF3b subunits
to the pre-mRNAonboth sides of the BPS, tethering theU2
snRNP for later steps (10,11,13,53,78). In this scenario, SF1
initiatesU2 snRNP recruitment and facilitates the events re-
quired for A complex formation by placing the U2 snRNP
into the vicinity of the BPS andU2AF65, whereas U2AF65
stabilizes the association of the U2 snRNPwith the spliceo-
some once SF1 is released.
The interaction of SF1 with U2 snRNP-associated pro-
teins is required for efficient spliceosome assembly, since
A3’ complex formation is strongly reduced following SF1
depletion and can be restored by addition of SF1 contain-
ing, but less so by addition of SF1 lacking the SURP-ID
(Figures 3 and 4). This effect is not due to the disruption
of the SF1/U2AF65 interaction, since both SF1 proteins
contain the ULM and pre-mRNA binding of U2AF65 was
not compromised in the presence of either protein (Fig-
ure 5). Guth and Valca´rcel (24) suggested a function of SF1
in addition to increasing the affinity of U2AF65 for the
polypyrimidine tract. The results presented here strongly
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suggest that this additional role is the binding of SF1 to the
U2 snRNP, thereby directly promoting theU2 snRNP/BPS
interaction.
Although SF1 has long been considered a constitutive
splicing factor, it is not required to splice all introns (22,25).
In these cases, U2AF65 may be sufficient to recruit the
U2 snRNP, perhaps helped by other proteins (80). Also,
U2AF65 may not be necessary for the recognition of 12%
of functional human 3′ splice sites (81); thus, SF1 may play
a major role in the recruitment of the U2 snRNP to introns
that are not bound by U2AF65.
The interaction of SF1 with SURP domains
The Y2H screens identified SURP1 of SF3a120, the sin-
gle SURP domain of CHERP and SURP2 of SFSWAP as
SF1 interaction partners, which was confirmed with recom-
binant proteins (Table 3, Figure 1 and Supplementary Fig-
ures S4–S11). The remaining SURP domains of SF3a120
and SFSWAP could not be tested, since the bacterially ex-
pressed proteins were insoluble (data not shown). However,
the following points argue that SF1 only interacts with the
SURP domains tested. First, although some of the cD-
NAs isolated in the Y2H screens completely or partially in-
cluded the other SURP domains of SF3a120 and SFSWAP,
SF3a120 SURP1 and SFSWAP SURP2 were present in
all cDNAs recovered. Second, Kuwasako et al. (66) only
obtained SURP2 of SF3a120 in soluble form when co-
expressedwith SF3a60. In analogy to these experiments, co-
expression of SF1 and SF3a120 SURP2 did not yield solu-
ble SURP2 (data not shown), suggesting that SF1 does not
interact with SF3a120 SURP2. Third, SURP domains can
be classified into two evolutionarily related subgroups (66).
The SURP domains of SF3a120, SFSWAP and CHERP
isolated in the SF1 Y2H screens belong to subgroup 1,
whereas SF3a120 SURP2 and SFSWAP SURP1 belong to
subgroup 2. It is therefore highly likely that SF1 only inter-
acts with SURP domains of subgroup 1, but not those of
subgroup 2.
The SF1 SURP-ID is located immediately C-terminal to
the zinc knuckle (Figure 2). Its sequence is almost invariant
in mammals and conserved to a lesser extent in A. thaliana
and S. pombe, but it is not present in S. cerevisiae SF1.
BLAST searches did not identify a related sequence in other
mammalian proteins. SF3a60 binds SURP2 of SF3a120
and single amino acid changes in SURP2 and SURP1 swap
the identity of the domains, i.e. prevent SURP2 binding of
SF3a60 but allow for SURP1 binding (66). It is therefore
intriguing to speculate that the interaction sites in SF3a60
and SF1 show a certain degree of similarity. A sequence
alignment between the SF1 and SF3a60 SURP-IDs does
not reveal obvious homology (data not shown). The SF3a60
SURP-ID forms a long amphipathic -helix (66) and an
equivalent interaction surface has been described between
the S. cerevisiae orthologs (68). Analysis with the Phyre2
protein fold recognition server (82) also predicts a heli-
cal structure for the SF1 SURP-ID (data not shown). Dif-
ferences in the mode of interaction would however be ex-
pected, since SF3a forms a stable heterotrimer (41), whereas
the SF1/SF3a120 interaction is dynamic and resolved at
the time of A complex assembly. Future structural stud-
ies should define similarities and differences in the binding
modes of SF3a60 and SF1 to SF3a120.
Lack of conservation of the SF1 SURP-ID in S. cerevisiae
Somewhat as a surprise, the SF1 SURP-ID is not con-
served in S. cerevisiae SF1 (BBP). In addition, SURP1 of
the yeast SF3a120 ortholog Prp21p lacks four amino acids
close to a 310 helix present in the human protein (66), which
could change the spatial organization of the interaction site.
This may suggest that BBP and Prp21p do not interact. In
fact, Y2H interactions between BBP and Prp21p have not
been detected (J.-C.R., unpublished results) and are also
not documented in the Saccharomyces Genome Database
(http://www.yeastgenome.org/).
Could the BBP/Prp21p interaction be dispensable in S.
cerevisiae? The vast majority of yeast introns contain the
consensus BPS, UACUAAC, (83) with a perfect comple-
mentarity to the BPS-interacting sequence of U2 snRNA
(G-UAGUA; the dash indicates the missing complementar-
ity to the bulged-out BPS adenosine). Given our observa-
tion that the SF1/U2 snRNP interaction is more important
for efficient splicing of introns with a weak BPS, SF1 may
thus not be required for U2 snRNP recruitment in yeast.
The SF1/SFSWAP interaction
SFSWAP was identified as an additional partner of SF1 in
Y2H screens frommouse tissues. SF1 binding to its SURP2
domain was confirmed in GST pull-down assays, but we
did not detect the interaction by anti-SF1 IP from HeLa
cell lysates. SFSWAP is an alternative splicing regulator
that also autoregulates the splicing of its own pre-mRNA
(65,69–72); however, targets of its regulation remain largely
unknown.Given that SF1 also acts as an alternative splicing
factor (25–28), the two proteins may physically interact to
regulate the splicing of perhaps only a few pre-mRNAs or
only in certain tissues, which could explain the failure to de-
tect the interaction in HeLa cells. Finding common splicing
substrates with appropriate methods could solve this ques-
tion.
Additional potential partners of SF1
Anti-SF1 antibodies co-precipitated only few proteins with-
out a reported connection to splicing (Table 1). Some of
these are involved in transcription, which may be related
to the published role for SF1 in transcription repression
(84,85). Similarly, several transcription factors were iden-
tified as potential partners of SF1 in the Y2H screens (e.g.
zinc finger-containing proteins).
The Y2H screens were informative concerning other po-
tential SF1 partners and structural domains mediating in-
teractions with SF1 (Table 3). KPNA2 was found as a prey
in all cell types tested with the highest-confidence PBS ob-
served. Other members of this family of nuclear import fac-
tors were also detected, but with lower PBS. SF1 is a nu-
clear protein and therefore its interaction with the nuclear
import machinery may not be surprising. However, Y2H
screens with other nuclear proteins did not find KPNAs in
such abundance (J.-C.R., unpublished data). The shortest
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selected interaction domain (SID) of the KPNAs com-
prises armadillo repeats, which are also found in the nuclear
pore complex protein Nup155, another prey of SF1. There-
fore, SF1 may have a thus far unknown function related to
nuclear import.
Another protein with a high PBS found in all cell types
analyzed is KIAA0907/BLOM7. It was initially identified
inY2H screens with a component of the human Prp19 com-
plex and has been shown to increase splicing in HeLa cell
nuclear extracts and regulate alternative splice site decisions
(60). BLOM7 contains two KH domains, the second of
which is comprised in the SF1 SID. Six additional pro-
teins with KH domains covered by the SID were found
as SF1 preys (KHDRBS1/SAM68; KHDRBS3/SLM-2;
KHSRP/FUBP2; hnRNPK; FUBP3; QKI), most of which
play roles in splicing (86–90). Interestingly, SF1 itself con-
tains aKHdomain of the same type as those ofKHDRBS1,
KHDRBS2, QKI and BLOM7.
KIAA0562/CEP104 is a centrosomal protein of 104 kDa
and another example of a prey identified in all cell types
with a high PBS. The SID of CEP104 does not comprise
any known structural domain and a potential role for a
SF1/CEP104 interaction is elusive.
In addition to these proteins, SF1 preys include RRM-
containing proteins, most of which with reported functions
in splicing. Interestingly, the SIDs of these proteins of-
ten comprise tandem RRMs. This observation may sug-
gest that SF1 not only binds proteins with non-canonical
RRMs of theUHMclass (47,48,51,91), but also other types
of RRMs. Taken together, the Y2H screens have provided
a vast amount of information about possible SF1 partners
and novel interaction domains, the relevance of which re-
mains to be investigated.
To conclude, our data demonstrate a new role for SF1
in the recruitment of the U2 snRNP to the spliceosome
by interaction with SURP domain-containing proteins and
the potential to regulate alternative splicing events through
a SURP domain-mediated interaction with SFSWAP. Our
findings moreover stress the function of SURP domains
as protein–protein interaction modules and future studies
may identify additional proteins interacting with SURP do-
mains. Furthermore, the Y2H screens identified potential
novel partners of SF1. Studying these interactions may re-
veal additional functions of SF1 in splicing and other cellu-
lar pathways.
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